Piper Sandler Upgrades Medtronic to Overweight
Moderately bullish analyst upgrade, with the target indicating more limited upside than the rating change alone may suggest.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Moderately bullish analyst upgrade, with the target indicating more limited upside than the rating change alone may suggest.
What happened, with direct paths to the underlying reporting
Piper Sandler upgraded MDT to Overweight and set a $120 target, compared with a posted price of $102.88. The target implies roughly 17% upside, though analyst targets are opinions.
Target: $120
Posted price: $102.88
Analyst firm: Piper Sandler
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.